Simulation of heart pacing for modeling arrhythmia

The cardiac simulator uses virtual pacing to analyze electrophysiological maps, efficiently identifying arrhythmia sources, thereby reducing invasive procedure time and complexity.

JP2024169732AInactive Publication Date: 2024-12-05BIOSENSE WEBSTER (ISRAEL) LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024169243
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-03-06
Filing Date
2024-09-27
Publication Date
2024-12-05
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing cardiac surgery techniques for isolating cardiac arrhythmia sources are invasive, time-consuming, and require manual repetition of pacing procedures at multiple locations, posing challenges in identifying precise arrhythmia locations.

Method used

A cardiac simulator and simulation method that uses computerized simulation (virtual pacing) to analyze electrophysiological maps, such as LAT and voltage maps, to identify and grade candidate locations for arrhythmias, reducing the need for manual invasive pacing.

Benefits of technology

This approach reduces the time and complexity of invasive procedures by accurately identifying arrhythmia sources, minimizing patient risk and procedural time, and optimizing treatment strategies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024169732000001_ABST
    Figure 2024169732000001_ABST
Patent Text Reader

Abstract

To perform simulations of an electrophysiological activity of a heart.SOLUTION: A cardiac simulation method includes storing, in a memory, a measured electrophysiological (EP) map of at least part of wall tissue of the heart of a patient. Based on the stored EP map, simulated electrical activity in response to computer-simulated pacing, which simulates actual electrical activity that would occur across the wall tissue of the heart of the patient in response to actual pacing, is calculated in a processor. Based on the simulated electrical activity calculated in the processor, one or more candidate locations on the wall tissue of the heart at which arrhythmia is suspected of originating are identified and indicated to a user.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates generally to clinical simulation, and more particularly to simulation of cardiac electrophysiological activity. [Background technology]

[0002] Cardiac surgery often uses techniques to isolate potential sources of cardiac arrhythmias in cardiac tissue. For example, U.S. Patent No. 5,722,416 describes a system and method for analyzing biopotential morphology in body tissue. The system and method uses a template of biopotential events of known cause in the body tissue. The template includes a plot of biopotential changes over time. The system and method compares the template to a sample of an externally induced biopotential event in the body tissue. The sample includes a plot of biopotential changes over time. The system and method generates an output based on the comparison. The system and method can be used to compare an event-specific template of a known diagnostic cardiac event to a sample of a paced cardiac event. The comparison results in a matching factor indicating how similar the input sample is to the input template. The system and method compares the matching factor to a predetermined value to determine the location of a site potentially suitable for ablation. A matching factor indicating a significant similarity between the sample and the template suggests that the pacing site is near a region potentially suitable for ablation to treat the arrhythmia.

[0003] As another example, U.S. Patent No. 5,041,973 describes a cardiac mapping system simulator that includes a microprocessor for simulating the electrical signal propagation of a heartbeat as it moves across the surface of the heart. A series of impulses that closely resemble electrophysiological waveforms are generated to form a two-dimensional map representative of the activity of the heart. The series of pulses are generated according to a predetermined pattern and are used to input the cardiac mapping system or electrophysiology lab equipment to assess the operating condition of the cardiac mapping system or electrophysiology lab equipment prior to use on a patient.

[0004] US Patent Application Publication No. 2015 / 0371437 describes a system and method for visualizing cardiac changes under various pacing conditions for intervention planning, and guidance is provided. A patient-specific anatomical cardiac model is generated based on the patient's medical image data. A patient-specific computational model of cardiac function is generated based on the patient-specific anatomical cardiac model. A virtual intervention is performed for each of a plurality of locations on the patient-specific anatomical cardiac model using the patient-specific computational model of cardiac function to calculate one or more cardiac parameters resulting from the virtual intervention performed for each of the plurality of locations. For each of the plurality of locations on the patient-specific anatomical cardiac model, one or more result maps are generated to visualize optimal values ​​of the one or more cardiac parameters resulting from the virtual intervention performed at that location on the patient-specific anatomical cardiac model. Summary of the Invention [Means for solving the problem]

[0005] An embodiment of the present invention provides a medical method that includes storing in a memory an electrophysiological (EP) map of at least a portion of a measured cardiac wall tissue of a patient. Based on the stored EP map, simulated electrical activity in response to computer-simulated pacing, simulating actual electrical activity occurring across the patient's cardiac wall tissue in response to actual pacing, is calculated in a processor. Based on the simulated electrical activity calculated in the processor, one or more candidate locations on the cardiac wall tissue where arrhythmia is suspected to have occurred are identified and presented to a user.

[0006] In some embodiments, the method includes storing one or more of a local activation time (LAT) map, a voltage map, and an adjusted LAT map, and the one or more locations include electroanatomical locations on the EP map.

[0007] In some embodiments, the method includes identifying one or more candidate locations by comparing the simulated electrical activity with actual electrical activity obtained at the patient's heart exhibiting the arrhythmia and finding the candidate location that provides the best match between the simulated electrical activity and the actual electrical activity.

[0008] In one embodiment, the method includes finding the best temporal match between the simulated electrical activity and the actual electrical activity.

[0009] In another embodiment, the method further includes assigning to one or more candidate locations a corresponding grade that quantifies the likelihood that the candidate location is a source of the arrhythmia.

[0010] In some embodiments, the method further includes presenting to the user grades assigned to the one or more candidate locations.

[0011] In some embodiments, the method includes updating the EP map with grades assigned to one or more candidate locations.

[0012] In one embodiment, the method includes receiving a user input via a user interface indicating one or more candidate locations.

[0013] According to an embodiment of the present invention, there is further provided a cardiac pacing simulator having a memory and a processor. The memory is configured to store an electrophysiological (EP) map of at least a portion of a measured cardiac wall tissue of a patient. The processor is configured to calculate a simulated electrical activity in response to computer-simulated pacing based on the stored EP map, the simulated electrical activity simulating actual electrical activity occurring across the patient's cardiac wall tissue in response to actual pacing. The processor is further configured to identify and indicate to a user one or more candidate locations on the cardiac wall tissue where an arrhythmia is suspected to have occurred based on the simulated electrical activity calculated in the processor.

[0014] The invention will be more fully understood when considered in conjunction with the drawings in which: [Brief description of the drawings]

[0015] [Figure 1] 1 is a schematic, pictorial illustration of a cardiac 3D navigation and electrophysiological signal analysis system in accordance with an embodiment of the present invention; [Diagram 2] 1 is a schematic, pictorial illustration of a cardiac local activation time (LAT) map in accordance with an embodiment of the present invention; [Diagram 3] 1 is a flow chart that generally illustrates a method for identifying locations on a LAT map where arrhythmias may begin by simulation, in accordance with an embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0016] Summary DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The embodiments of the invention described herein provide a cardiac simulator and simulation method for identifying, estimating and grading locations on the cardiac surface where arrhythmias may occur.

[0017] Cardiac arrhythmias are defined as variations from normal heart rate and / or rhythm and can fall into several categories. One category is characterized by increased or abnormal impulse generation (from sites in the cardiac tissue of abnormal focal excitation). Another category is characterized by disturbances in electrical conduction at a variety of possible locations across the surface of the heart.

[0018] One possible method to find the location where the arrhythmia occurs is to stimulate selected locations on the patient's cardiac surface with electrical signals in an attempt to generate an actual arrhythmia that matches a previously recorded patient arrhythmia. The quality of the match may take into account factors such as the morphology, sequence, and associated time intervals measured by the system. The underlying premise is that treating such locations is more likely to reduce or eliminate the arrhythmia in question, for example by applying ablation. The invasive diagnostic procedure described above is called "pacing", while the process of comparison is called "pace mapping". Pacing is typically a lengthy process, as it must be manually repeated over multiple locations in the heart.

[0019] In some embodiments of the invention, the pacing procedure described above is replaced with a computerized simulation, also referred to herein as "virtual pacing." In some embodiments, the cardiac simulator comprises a processor that stores a pre-acquired electrophysiological map of at least a portion of the surface of the patient's heart. One example of such an electrophysiological map is referred to herein as a local activation time (LAT) map. The LAT map reveals the time-dependent propagation of initiated electrical signals (electric potentials) through the myocardium and connective tissues that comprise the heart, as further described below.

[0020] A variation of the LAT map is also in use in some embodiments of the present invention, hereinafter referred to as an "adjusted LAT map". The adjusted LAT map is an LAT map optimized to increase coherence, as described in U.S. Patent No. 9,050,011 and U.S. Patent Application Publication No. 2017 / 0281031, which are assigned to the assignee of the present patent application and the disclosures of which are incorporated herein by reference in their entirety. Another example of such an electrophysiological map is referred to herein as a voltage map, in which the voltage at each electroanatomical location is recorded and converted into a color-coded map to identify diseased tissue, healthy tissue, and scar regions. In some embodiments, simulated pacing calculations are performed using only the LAT map without using any other type of map. In some embodiments, the source placement of candidates for virtual pacing may also be defined using the voltage map. For example, a good candidate is the border region of the scar or isthmus region.

[0021] In another embodiment of the invention, one or more LAT maps may be used, for example, one LAT map formed during sinus rhythm and another LAT map formed during some arrhythmias or during pacing.

[0022] To identify locations where arrhythmias may occur, the processor uses additional input from the voltage map and the adjusted LAT map to simulate the propagation of electrical activity from one or more candidate locations on the LAT map. The processor simulates such activity in a process hereinafter termed "simulated pacing." The processor calculates the propagation of electrical activity resulting from one or more virtually paced potentials at various locations on the LAT and / or adjusted LAT maps.

[0023] The processor typically forms a new LAT map based on a selected location of the initial virtual pace and the approximated time difference between this location and each point of the anatomical mesh taking into account radio wave propagation. ■ The onset time (t=0) is defined as the activation time at the selected location of the simulated pacing. ■Calculation of the arrival time of radio waves propagated to every point of the anatomical mesh was based on the difference between the actual LAT map (or multiple maps) and / or based on refinements added to the LAT map using an adjusted LAT map application.

[0024] The processor then compares the simulated electrical activity resulting from the simulation with the actual time intervals of clinically recorded arrhythmias (ie, the time of electronic conductance decay through the ventricles).

[0025] In one embodiment, the processor further assigns a grade to the virtually paced locations that quantifies the likelihood that the candidate location is a source of arrhythmia based on a comparison of the measured time intervals, and the grade can be used by a physician to optimize subsequent diagnostic and therapeutic steps.

[0026] The performance of simulated pacing with the disclosed technology guides the physician to expected locations where arrhythmias may begin. Thus, the simulation may reduce the number of pacing steps the physician needs to perform during an invasive procedure. Furthermore, the disclosed technology is free of time limitations and other constraints associated with real invasive pacing procedures (such as catheter movement between pacing locations, which may require steering the catheter to locations or regions of the heart that are difficult to reach and where it is also difficult to stabilize the catheter). Thus, the disclosed systems and methods may increase the physician's chances of success with subsequent invasive cardiac therapy. Furthermore, the simulation may eliminate many locations in the cardiac tissue from being considered as candidate sources of arrhythmias, guiding the physician to other causes of arrhythmias, potentially shortening the procedure time and simplifying the workflow.

[0027] The disclosed technique of simulated pacing has the potential advantages of shortening the time of invasive diagnostic procedures and reducing hand fatigue and difficult catheter manipulation by incorporating a "virtual pacing" procedure step on a computer screen instead of moving a catheter to a desired location and pacing with the catheter. Furthermore, the disclosed technique has the potential to reduce the burden of pacing on the patient's heart, avoiding the potential risks of long-term cardiac remodeling, as well as the risk of inducing hemodynamically unstable arrhythmias in the patient that could endanger the patient's life.

[0028] System Description FIG. 1 is a schematic pictorial diagram of a cardiac 3D navigation and electrophysiological signal analysis system 20 according to an embodiment of the present invention. The system 20 may be configured to analyze virtually any physiological parameter or combination of such parameters. In the present description, by way of example, it is assumed that the analyzed signals are potential-time relationships of intracardiac (IC) and / or extracardiac (body surface-BS) electrocardiograms (ECGs). To fully characterize such relationships, it is necessary to reference the signals to each other in time at various locations (e.g., as may be done during the generation of the LAT map). The time referencing is achieved by measuring relative to a reference time (e.g., instance), such as the beginning of each QRS complex (i.e., the beginning of every heartbeat) of an ECG reference signal. A method for generating LAT maps is described in the aforementioned U.S. Pat. No. 9,050,011.

[0029] For simplicity and clarity, the following description assumes, unless otherwise noted, an investigation procedure in which the system 20 uses a probe 24 to measure actual electrical activity of the heart 34. The distal end 32 of the probe is assumed to have an electrode 22. The measured signal is used to generate a LAT map of at least a portion of the wall tissue of the heart 34 of the patient 26, which may be shared, among other applications.

[0030] Typically, probe 24 comprises a catheter that is inserted into the body of patient 26 during a mapping procedure performed by a physician 28 using system 20. During the procedure, patient 26 is assumed to be attached to a ground electrode 23. In addition, electrode 29 is assumed to be attached to the skin of patient 26 in the region of the heart 34.

[0031] The system 20 may be controlled by a system processor 40, which includes a processing unit 42 in communication with a memory 44. In some embodiments, the system processor 40 includes a memory 44 that stores a LAT and / or voltage map 62 of at least a portion of the wall tissue of the heart 34 of the patient 26. Additionally or alternatively, the memory 44 may store maps of other patients. Furthermore, any other processor with memory (i.e., not necessarily part of the system 20) may store one or more maps. The processor 40 is typically mounted in a control console 46, which includes a control 38, typically having a pointing device 39, such as a mouse or trackball, by which the professional 28 interacts with the processor.

[0032] The processor 40 (specifically the processing unit 42) executes software including the probe tracking module 30, the ECG module 36, and the arrhythmia simulation module including the LAT analysis module 35 to operate the system 20 and / or for the LAT analysis module 35 to perform a simulation of cardiac pacing (using the LAT or adjusted LAT map 62 stored in the memory 44) resulting in a model of the arrhythmia. The simulated cardiac pacing may be achieved by the physician 20 or a co-operator clicking on the screen at the desired location for the simulated pacing, or in any other manner. The proposed area for the simulated pacing may also be displayed by the processor 40.

[0033] The results of the operations performed by processor 40 are presented to physician 28 on display 48, which typically presents a graphic user interface to the physician, a visual representation of the ECG signals sensed by electrodes 22, and / or an image or map of heart 34 while it is being studied. In one embodiment, LAT analysis module 35 presents to the physician a LAT map updated with one or more locations on the map where simulated arrhythmias occurred. The software may be downloaded to processor 40 in electronic form, for example over a network, or alternatively or additionally may be provided and / or stored on a non-transitory tangible medium, such as magnetic, optical, or electronic memory.

[0034] An ECG module 36 is coupled to receive the actual electrical signals from electrodes 22 and 29. The module is configured to analyze the actual signals and is capable of presenting the results of the analysis on a display 48 in a standard ECG format, typically in a graphical representation of variations over time.

[0035] Probe tracking module 30 tracks the position of distal end 32 of probe 24 within the heart of patient 26. The tracking module may use any probe position tracking method known in the art. For example, module 30 may operate a magnetic field-based position tracking subsystem (for simplicity, components of such a subsystem are not shown in FIG. 1 ).

[0036] Alternatively or additionally, tracking module 30 may track probe 24 by measuring the impedance between electrodes 23, 29, and 22, as well as the impedance to other electrodes that may be disposed on the probe (in which case electrodes 22 and / or 29 may provide both ECG and position tracking signals). The Carto3® system, manufactured by Biosense Webster (Irvine, California), uses both magnetic field position tracking and impedance measurements for position tracking.

[0037] Using the tracking module 30, the processor 40 can measure the location of the distal tip 32. Additionally, by using both the tracking module 30 and the ECG module 36, the processor can measure not only the location of the distal tip, but also the LAT of the actual electrical signal detected at these particular locations. For clarity, in this disclosure and claims, measured locations of the distal tip that do not have an associated LAT measurement are referred to herein as non-LAT locations and are used only to generate anatomical components of a three-dimensional (3D) LAT map of the inner wall tissue of the heart 34. Measured locations of the distal tip that have a corresponding LAT measurement are referred to as LAT locations and are subsequently used to attempt to simulate arrhythmias.

[0038] Simulation of cardiac pacing for modeling arrhythmias FIG. 2 is a schematic pictorial diagram of a LAT map 62 of the heart 34, according to an embodiment of the present invention. For simplicity, only a portion of the complete map of the inner wall tissue is shown in FIG. 2. The LAT map 62 is formulated as a mesh with multiple non-LAT location points 64, the locations of which have been evaluated by the tracking module 30 to generate the anatomical components of the map 62. In one embodiment, the processor 40 connects the points 64 by straight inter-point lines 66 to form a mesh of connected planar triangles 70. The connected triangles 70 form a surface that approximates the inner heart wall tissue surface. Other methods of anatomical reconstruction may be applied (e.g., CARTO® SEG CT / MRI import, etc.), and other representations of the reconstruction may be used (such as meshes generated from rapid anatomical mapping).

[0039] Map 62 also shows LAT locations 68, each having an associated LAT value (simply referred to as "LAT"). Typically, the LAT locations and their associated LATs are evaluated for different time periods from the time used by processor 40 to generate the anatomical components of map 62. For non-LAT locations, the LAT locations are adjusted to a reference time to compensate for cardiac wall motion, among other reasons. Theoretically, LAT locations 68 should be aligned with the surface of triangle 70, since both types of locations, LAT and non-LAT locations, should be on the cardiac tissue wall.

[0040] The electrical activity of the heart can be thought of as a wave of electrical potentials that initiates at the beginning of each heartbeat in the sinoatrial node and propagates through the myocardium. At any point on the wall of the heart chamber, the LAT at that point is produced by the electrical potential propagating past that point.

[0041] In the LAT map 62, one or more LAT locations 68 designate actual signal pacing locations, i.e., locations where actual electrical signals were injected into the heart wall tissue by the catheter electrodes 22 in the process of generating the map. The LAT locations 68 designate measurement locations where resultant electrical activity (in response to the injected actual signals) was sensed to measure respective LAT values.

[0042] In an embodiment, the LAT analysis module 35 applies the simulated electrical activity propagation to identify a virtually paced location 68A that provides the best time match between the simulated LAT pattern resulting (i.e., by simulation) at the different locations 68B and the recorded clinical arrhythmia. For example, the best match may be obtained between virtual pacing resulting in a virtual LAT map and virtual time intervals and the time interval characteristics of the recorded arrhythmia.

[0043] In some embodiments, the LAT analysis module 35 updates the LAT map 62 with one or more locations that are presumed to be potential sources of arrhythmia during simulated stimulation. The LAT analysis module 35 further assigns grades to the LAT locations that quantify the likelihood that these candidate locations are sources of arrhythmia. The LAT analysis module 35 numerically and / or graphically updates the LAT map 62 with the grades from the one or more locations. The simulated pacing location 68A that receives the highest grade may serve as a priority location for a physician to try during catheterization to generate an acquired signal corresponding to a recorded arrhythmia. The physician may then, for example, ablate tissue near the clinically identified location to isolate such.

[0044] 3 is a flow chart that generally illustrates a method for identifying locations on the LAT map 62 where arrhythmias may begin, in accordance with an embodiment of the present invention. The locations are identified by generating simulated excitation generated by virtual pacing, resulting from previously collected electroanatomical signals.

[0045] The procedure may begin with the construction of a LAT map or adjusted LAT map based on the measured LAT map 62, where in an initial step 70, analysis module 35 calculates all LAT data and places the data in map 62 stored in memory 44. Next, in step 72, a virtual source 68A (i.e., the initial point of simulated pacing) is selected by the processor or user. LAT analysis module 35 takes into account the actual propagation data and calculates propagation from the virtual source in step 74.

[0046] The method now proceeds to an analysis step 76 in which the LAT analysis module 35 assigns a grade to the particular pacing location 68A that quantifies the likelihood that the candidate location is a source of arrhythmia. In one embodiment, the LAT analysis module 35 adds an indicator, such as a grade or a graphical one, to the LAT map 62 in an update map step 78.

[0047] The procedure may be repeated by LAT analysis module 35 selecting another virtually paced location 68A, at which point the method returns to step 72 to select the initial point.

[0048] The exemplary flow chart shown in Figure 3 has been selected for conceptual clarity only: alternative embodiments may perform different steps to assess the location of the arrhythmia, such as using alternative electrophysiological maps and / or simulation steps and performing the above in a different order.

[0049] Although the embodiments described herein primarily address the treatment of ischemic ventricular tachycardia, the methods and systems described herein may also be used for other applications, such as any focal or reentrant arrhythmia.

[0050] It will therefore be understood that the above-described embodiments are cited by way of example, and that the present invention is not limited to what has been particularly shown and described above. Rather, the scope of the present invention includes both combinations of the various features described above and subcombinations thereof, as well as variations and modifications thereof that would occur to those skilled in the art upon reading the above description and that are not disclosed in the prior art. Documents incorporated by reference into this patent application are to be considered as part of this application, except that if any term is defined in these incorporated documents in a manner that is inconsistent with the definition expressly or impliedly given herein, then only the definition in this specification shall be considered.

[0051] [Embodiment] (1) A cardiac simulation method, comprising: storing in a memory a measured electrophysiological (EP) map of at least a portion of the patient's cardiac wall tissue; calculating, in a processor, a simulated electrical activity in response to computer-simulated pacing based on the stored EP map, the simulated electrical activity simulating actual electrical activity occurring across the wall tissue of the patient's heart in response to actual pacing; and identifying and indicating to a user one or more candidate locations on the wall tissue of the heart where an arrhythmia is suspected to have occurred based on the simulated electrical activity calculated in the processor. (2) The method of embodiment 1, wherein storing the EP map includes storing one or more of a local activation time (LAT) map, a voltage map, and an adjusted LAT map, and the one or more locations include electroanatomical locations on the EP map. (3) The method of embodiment 1, wherein identifying the one or more candidate locations includes comparing the simulated electrical activity with the actual electrical activity exhibiting the arrhythmia obtained at the patient's heart, and finding the candidate location that provides the best match between the simulated electrical activity and the actual electrical activity. (4) The method of embodiment 3, wherein finding the best fit comprises finding a best temporal match between the simulated electrical activity and the actual electrical activity. (5) The method of embodiment 1, further comprising assigning to the one or more candidate locations a corresponding grade that quantifies the likelihood that the candidate location is the source of the arrhythmia.

[0052] (6) The method of embodiment 5, further comprising presenting to a user the grades assigned to the one or more candidate positions. (7) The method of embodiment 6, wherein presenting the grade includes updating the EP map with the grade assigned to the one or more candidate locations. (8) The method of embodiment 1, wherein identifying the one or more candidate locations includes receiving user input indicating the one or more candidate locations via a user interface. (9) A cardiac pacing simulator, comprising: a memory configured to store a measured electrophysiological (EP) map of at least a portion of the patient's cardiac wall tissue; 1. A processor comprising: calculating simulated electrical activity in response to computer-simulated pacing based on the stored EP map, the simulated electrical activity simulating actual electrical activity occurring across the wall tissue of the patient's heart in response to actual pacing; and a processor configured to identify and indicate to a user one or more candidate locations on the wall tissue of the heart where an arrhythmia is suspected to have occurred based on the simulated electrical activity calculated in the processor. (10) The simulator of embodiment 9, wherein the stored EP maps include one or more of a local activation time (LAT) map, a voltage map, and an adjusted LAT map, and the one or more locations include electroanatomical locations on the EP maps.

[0053] (11) The simulator of embodiment 9, wherein the processor is configured to identify the one or more candidate locations by comparing the simulated electrical activity with the actual electrical activity acquired at the patient's heart exhibiting the arrhythmia and finding the candidate location that provides the best match between the simulated electrical activity and the actual electrical activity. (12) The simulator of embodiment 11, wherein the processor is configured to find the best match by finding a best temporal match between simulated electrical activity and the actual electrical activity. (13) The simulator of embodiment 9, wherein the processor is configured to assign to the one or more candidate locations a corresponding grade that quantifies the likelihood that the candidate location is a source of the arrhythmia. (14) The simulator of embodiment 13, wherein the processor is further configured to present to a user the grades assigned to the one or more candidate positions. (15) The simulator of embodiment 14, wherein the processor is configured to present the grade by updating the EP map with the grade assigned to the one or more candidate locations.

[0054] (16) The simulator of embodiment 9, further comprising a user interface configured to receive user input indicating the one or more candidate locations.

Claims

1. 1. A method of operating a cardiac pacing simulator comprising a memory and a processor, comprising: the processor: storing in the memory measured electrophysiological (EP) maps of at least a portion of the patient's cardiac wall tissue, including storing one or more of a local activation time (LAT) map, a voltage map, and an adjusted LAT map; simulating propagation of electrical activity from one or more locations on the EP map, calculating simulated electrical activity resulting from one or more virtually paced potentials; and identifying and presenting to a user one or more candidate locations on the wall tissue of the heart that are suspected of generating arrhythmias based on comparing the simulated electrical activity with actual electrical activity exhibiting arrhythmias obtained in the patient's heart and finding the candidate location that provides the best match between the simulated electrical activity and the actual electrical activity obtained in the patient's heart that is exhibiting arrhythmias from among the one or more locations.

2. The method of claim 1 , wherein the processor assigns a grade to the one or more candidate locations that quantifies the likelihood that the candidate location is a source of arrhythmia.

3. The method of claim 2 , wherein a display presents to a user the grades assigned to the one or more candidate locations.

4. The method of claim 3 , wherein presenting the grade comprises updating the EP map with the grade assigned to the one or more candidate locations.

5. 2. The method of claim 1, wherein the processor identifies one or more locations on the EP map by receiving user input via a user interface indicating one or more locations on the EP map.

6. 1. A cardiac pacing simulator, comprising: a memory configured to store measured electrophysiological (EP) maps of at least a portion of the patient's cardiac wall tissue, the EP maps including one or more of a local activation time (LAT) map, a voltage map, and an adjusted LAT map; 1. A processor, comprising: simulating propagation of electrical activity from one or more locations on the EP map, calculating simulated electrical activity resulting from one or more virtually paced potentials; a processor configured to identify and indicate to a user one or more candidate locations on the wall tissue of the heart that are suspected of causing arrhythmia based on comparing the simulated electrical activity with actual electrical activity exhibiting arrhythmia obtained in the patient's heart and finding, from among the one or more locations, a candidate location that provides a best match between the simulated electrical activity and the actual electrical activity obtained in the patient's heart, and

7. The simulator of claim 6 , wherein the processor is configured to assign to the one or more candidate locations a grade that quantifies the likelihood that the candidate location is a source of arrhythmia.

8. The simulator of claim 7 , wherein the processor is further configured to present to a user the grades assigned to the one or more candidate locations.

9. The simulator of claim 8 , wherein the processor is configured to present the grade by updating the EP map with the grade assigned to the one or more candidate locations.